Dr. Garber's research is directed toward methods for improving health care delivery and financing, particularly for the elderly, in settings of limited resources.

Dr. Krensky's laboratory focuses on using knowledge about the basic mechanisms of T lymphocyte biology in order to design novel immunotherapies for use in infectious diseases, transplantation, cancer, and autoimmune diseases.

Dr. Schatzberg's current research is in biological bases of depressive disorders, glucocorticoid/dopamine interactions in delusional depression, and pharmacologic treatment of depressive disorders.